Roche Under Fire Over ‘Unaffordable’ COVID-19 Therapy Actemra
The WHO Calls For Lower Prices
Executive Summary
The World Health Organization has taken the unusual step of calling for lower drug prices to help patient access IL-6 therapies in developing nations.